Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about IVBIY
Recent news which mentions IVBIY
FDA Rejects Lilly's Sintilimab/Chemo Combo Therapy In First-Line Lung Cancer Setting
March 24, 2022
Tickers
IVBIY
IVBXF
LLY
Tags
Health Care
Biotech
LLY
From
Benzinga
FDA AdComm Votes Against Lilly's Lung Cancer Drug, Sintilimab
February 11, 2022
Tickers
IVBIY
IVBXF
LLY
Tags
lung cancer
News
Briefs
From
Benzinga
Innovent Biologics, UNION therapeutics Ink Licensing Pact For Inflammatory Dermatology Candidate
September 28, 2021
Tickers
IVBIY
IVBXF
Tags
Health Care
General
Contracts
From
Benzinga
Innovent Biologics, Bolt Join Forces To Develop Anti-Cancer Candidates
August 27, 2021
Tickers
BOLT
IVBIY
IVBXF
Tags
IVBIY
IVBXF
Briefs
From
Benzinga
Innovent's Sintilimab/Chemo Regime Shows Overall Survival Benefit In Gastric Cancer
August 16, 2021
Tickers
IVBIY
IVBXF
LLY
Tags
General
News
Briefs
From
Benzinga
Innovent - Eli Lilly's Sintilimab Combo Shows Sustained Survival Benefit In Lung Cancer Patients
August 06, 2021
Tickers
IVBIY
IVBXF
LLY
Tags
Non/Small Cell Lung Cancer
IVBIY
IVBXF
From
Benzinga
Innovent Biologics - Incyte's Pemigatinib Application Under Review In China For Bile Duct Cancer
July 09, 2021
Tickers
INCY
IVBIY
IVBXF
Tags
Bile Duct Cancer
Biotech
Health Care
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.